These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6949617)

  • 1. Growth characteristics of leukemic and normal hematopoietic cells in Ph' + chronic myelogenous leukemia and effects of intensive treatment.
    Goto T; Nishikori M; Arlin Z; Gee T; Kempin S; Burchenal J; Strife A; Wisniewski D; Lambek C; Little C; Jhanwar S; Chaganti R; Clarkson B
    Blood; 1982 Apr; 59(4):793-808. PubMed ID: 6949617
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytogenetic studies of early myeloid progenitor compartments in Ph1-positive chronic myeloid leukemia. II. Long-term culture reveals the persistence of Ph1-negative progenitors in treated as well as newly diagnosed patients.
    Dubé ID; Kalousek DK; Coulombel L; Gupta CM; Eaves CJ; Eaves AC
    Blood; 1984 May; 63(5):1172-7. PubMed ID: 6585234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of blastic transformation in chronic myelogenous leukemia.
    Barton JC; Conrad ME
    Am J Hematol; 1978; 4(3):281-91. PubMed ID: 362906
    [No Abstract]   [Full Text] [Related]  

  • 4. Origin of chronic myelocytic leukemia in a precursor of pre-B lymphocytes.
    LeBien TW; Hozier J; Minowada J; Kersey JH
    N Engl J Med; 1979 Jul; 301(3):144-7. PubMed ID: 313004
    [No Abstract]   [Full Text] [Related]  

  • 5. The Philadelphia chromosome in human macrophages.
    Golde DW; Burgaleta C; Sparkes RS; Cline MJ
    Blood; 1977 Mar; 49(3):367-70. PubMed ID: 264792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of mast cell growth factor (c-kit ligand) on clonogenic leukemic precursor cells.
    Goselink HM; Williams DE; Fibbe WE; Wessels HW; Beverstock GC; Willemze R; Falkenburg JH
    Blood; 1992 Aug; 80(3):750-7. PubMed ID: 1638026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of treatment of Ph'+ chronic myelogenous leukemia with an intensive treatment regimen (L-5 protocol).
    Cunningham I; Gee T; Dowling M; Chaganti R; Bailey R; Hopfan S; Bowden L; Turnbull A; Knapper W; Clarkson B
    Blood; 1979 Mar; 53(3):375-95. PubMed ID: 282922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cells and probably B cells arise from the malignant clone in chronic myelogenous leukemia.
    Fauser AA; Kanz L; Bross KJ; Löhr GW
    J Clin Invest; 1985 Mar; 75(3):1080-2. PubMed ID: 3920244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic myelogenous leukemia. Acute transformation].
    Uzuka Y
    Rinsho Ketsueki; 1984 Mar; 25(3):288-98. PubMed ID: 6590887
    [No Abstract]   [Full Text] [Related]  

  • 10. Transformation of chronic myelogenous leukemia: clinical, morphologic, and cytogenetic features.
    Muehleck SD; McKenna RW; Arthur DC; Parkin JL; Brunning RD
    Am J Clin Pathol; 1984 Jul; 82(1):1-14. PubMed ID: 6588747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavior of human leukemic progenitor populations in long-term marrow culture.
    Eaves C; Coulombel L; Dubé I; Kalousek D; Cashman J; Eaves A
    Haematol Blood Transfus; 1985; 29():163-7. PubMed ID: 3861477
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro response to erythropoietin in erythroblastic transformation of chronic myelogenous leukemia.
    Greenberg BR; Hirasuna JD; Woo L
    Exp Hematol; 1980 Jan; 8(1):52-6. PubMed ID: 6931816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Human bone marrow organ cultures from trephination material].
    Kolesnikova AI; Luriia EA; Vorob'ev AI; Domracheva EV; Smirnov AN
    Probl Gematol Pereliv Krovi; 1978 Mar; 23(3):23-6. PubMed ID: 273892
    [No Abstract]   [Full Text] [Related]  

  • 14. [Molecular biology and functions of interleukin 3, a growth factor for bone marrow cells].
    Pajus I; Boffa GA
    Rev Fr Transfus Hemobiol; 1989 Feb; 32(1):37-54. PubMed ID: 2655645
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term marrow culture reveals chromosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome-positive chronic myelogenous leukemia.
    Coulombel L; Kalousek DK; Eaves CJ; Gupta CM; Eaves AC
    N Engl J Med; 1983 Jun; 308(25):1493-8. PubMed ID: 6574315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal culture and cytogenetics. Indicators of a variant of chronic myelogenous leukemia.
    Selvaggi S; Wolman SR; Bornstein S; Edinger F
    Cancer; 1984 Dec; 54(12):2956-8. PubMed ID: 6594190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in granulocyte-monocyte colony-forming cells among leukocyte-interferon-treated chronic myelogenous leukemia patients.
    Talpaz M; Spitzer G; Hittelman W; Kantarjian H; Gutterman J
    Exp Hematol; 1986 Aug; 14(7):668-71. PubMed ID: 3460811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapeutic sensitivity of normal and leukemic hematopoietic progenitor cells to N-[4-(9-acridinylamino)-3-methoxyphenyl]-methanesulfonamide, a new anticancer agent.
    Spiro TE; Socquet M; Delforge A; Stryckmans P
    J Natl Cancer Inst; 1981 Apr; 66(4):615-8. PubMed ID: 6939909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Philadelphia-chromosome-negative chronic myelogenous leukemia with lymphoid stem cell blastic transformation.
    Kessler JF; Grogan TM; Greenberg BR
    Am J Hematol; 1985 Feb; 18(2):201-6. PubMed ID: 3855600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neoplastic transformation of the pluripotential stem cell. II. Regeneration and differentiation of populations of leukemic blast cells].
    Rupniewska ZM
    Acta Haematol Pol; 1985; 16(1-2):102-8. PubMed ID: 3914169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.